GlassScriptPhysician profile
Travis R Graves
NPI 1922394840
$2,173.00
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $556 · 2020: $114 · 2021: $110 · 2022: $491 · 2023: $902.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $902.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $901.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $599.35 | 2019-2023 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Boston Scientific Corporation | $285.38 | 2022-2023 | Watchman Access System, Watchman |
| Astrazeneca Pharmaceuticals LP | $207.76 | 2019-2023 | Breztri, Fasenra |
| Grifols USA, LLC | $184.55 | 2019-2023 | Prolastin-C Liquid |
| Philips North America LLC | $156.94 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $114.59 | 2019-2023 | Recarbrio, Dificid, Zerbaxa |
| Bayer Healthcare Pharmaceuticals INC. | $83.55 | 2019-2023 | |
| Inspire Medical Systems, INC. | $61.44 | 2023 | Inspire |
| Baxter Healthcare | $49.06 | 2023 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Vapotherm INC | $44.00 | 2020 | |
| Johnson & Johnson Health Care Systems INC. | $38.50 | 2023 | Axert |
| Portola Pharmaceuticals, LLC | $33.72 | 2019 | |
| Biosense Webster, INC. | $33.03 | 2023 | Octaray Mapping Catheter |
| Takeda Pharmaceuticals U.S.A., INC. | $32.16 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $30.87 | 2019-2023 | Dupixent |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $27.77 | 2021-2022 | |
| Fisher & Paykel Healthcare INC | $25.84 | 2022 | |
| Electromed, INC. | $23.47 | 2021 | |
| Mylan Specialty L.P. | $21.87 | 2019 | |
| Harmony Biosciences LLC | $20.91 | 2022 | |
| Genzyme Corporation | $20.80 | 2023 | |
| Abbvie INC. | $19.94 | 2022 | |
| Gilead Sciences, INC. | $15.69 | 2021 | |
| Mallinckrodt Enterprises LLC | $14.15 | 2019 | |
| Pfizer INC. | $13.95 | 2019 | |
| Amgen INC. | $13.71 | 2023 | Tezspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Graves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.